Does short-term androgen depletion add to high dose radiotherapy (80 Gy) in localized intermediate risk prostate cancer? Final analysis of GETUG 14 randomized trial (EU-20503/NCT00104741)

被引：20

作者：

Dubray, Bernard M.

Salleron, Julia

Guerif, Stephane Gilles

Le Prise, Elisabeth

Reynaud-Bougnoux, Agnes

Hannoun-Levi, Jean-Michel

Tan Dat Nguyen

Hennequin, Christophe

Cretin, Jacques

Fayolle-Campana, Maryse

Lagrange, Jean-Leon

Bachaud, Jean-Marc

Azria, David

Grangirard, Alain

Pommier, Pascal

Simon, Jean-Marc

Habibian, Muriel

Bey, Pierre

Beckendorf, Veronique

机构：

[1] CRLCC Henri Becquerel, Rouen, France

[2] Inst Cancerol Lorraine, Nancy, France

[3] Univ Hosp Poitiers, Poitiers, France

[4] Ctr Eugene Marquis, Rennes, France

[5] CHU Bretonneau, Tours, France

[6] Ctr Antoine Lacassagne, Nice, France

[7] Inst Jean Godinot, Reims, France

[8] Hop St Louis, Dept Radiat Oncol, Paris, France

[9] Clin Valdegour, Nimes, France

[10] HIA Val de Grace, Paris, France

[11] CHU Henri Mondor, Creteil, France

[12] CRLCC Claudius Regaud, Toulouse, France

[13] Inst Reg Canc, Montpellier, France

[14] Hop Hasenrain, Mulhouse, France

[15] CRLCC Leon Berard, Lyon, France

[16] CHU Pitie Salpetriere, Paris, France

[17] UNICANCER, Paris, France

[18] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.5021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5021

引用

页数：2